Addiction Medicine
News
New buprenorphine formulation approved for medication-assisted treatment
Patients who are currently taking other buprenorphine formulations can be transitioned.
Commentary
Luxury drug treatment centers: Close scrutiny advised
Addiction experts say patients’ success is more a function of evidence-based strategies than high costs.
Latest News
CMS to enlist Medicare Part D plans to combat opioid abuse
Officials would like to extend the use the criteria for overutilizers to identify at-risk beneficiaries, then allow insurers to limit their access...
Commentary
Ending hazing as a rite of manhood on college campuses
Is hazing a necessary rite of passage in Greek life, or a terrible tradition that needs to end once and for all?
From the Journals
Carefully monitor cannabis-using patients in opioid-agonist therapy
Heavy cannabis users were 48.1% more likely to drop out of OAT than those who weren’t heavy users.
News
FDA clears first-ever neurostimulation device for opioid withdrawal symptoms
In one study, almost 90% of patients transitioned to medication-assisted treatment after 5 days of using the device.
From the Journals
New persistent opioid use common after cancer surgery
One year after surgery, patients who developed new persistent opioid use were still filling prescriptions at high daily opioid doses, equivalent...
Feature
White House opioid panel calls for more addiction specialists
Experts recommend some payment changes regarding pain management as well.
News
FDA panels support two NDAs for buprenorphine subcutaneous injections
The panelists agree that subcutaneous formulations might help step the opioid epidemic.
Commentary
Vaping marijuana?
Cannavaping—the inhalation of a cannabis-containing aerosol, created by a battery-driven, heated atomizer in e-cigarettes or similar devices1...
News from the FDA/CDC
Fentanyl analogues an increasing factor in opioid deaths
Almost 30% of opioid overdose deaths in Maine involved carfentanil or similar products.